Metabolic alterations and mitochondrial dysfunction underlie hepatocellular carcinoma cell death induced by a glycogen metabolic inhibitor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metabolic alterations and mitochondrial dysfunction underlie hepatocellular carcinoma cell death induced by a glycogen metabolic inhibitor

Published:2022-09 Issue: Volume:203 Page:115201
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Barot Shrikant,Stephenson Olivia J.,Priya Vemana Hari,Yadav Anjali,Bhutkar Shraddha,Trombetta Louis D.,Dukhande Vikas V.

Funder

St. John's University

National Institutes of Health

Foundation for the National Institutes of Health

National Institute of General Medical Sciences

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference40 articles.

1. Cancer Statistics, 2021;Siegel;CA A Cancer J. Clin.,2021

2. Molecular Bases of Drug Resistance in Hepatocellular Carcinoma;Marin;Cancers (Basel),2020

3. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

4. Hallmarks of Cancer: New Dimensions;Hanahan;Cancer Discovery,2022

5. Understanding the Warburg effect: the metabolic requirements of cell proliferation;Vander Heiden;Science,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic Efficacy of CDK4/6 Inhibitor Abemaciclib and HDAC Inhibitor Panobinostat in Pancreatic Cancer Cells;Cancers;2024-07-30

2. Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight;Metabolites;2024-06-08

3. Interventing mitochondrial PD-L1 suppressed IFN-γ-induced cancer stemness in hepatocellular carcinoma by sensitizing sorafenib-induced ferroptosis;Free Radical Biology and Medicine;2024-02

4. CHIR-98014, a GSK 3β Inhibitor, Protects Against Triptolide/Lipopolysaccharide-Induced Hepatotoxicity by Mitochondria-Dependent Apoptosis Inhibition;Chemical Research in Toxicology;2024-01-29

5. Recent advancement in targeted therapy and role of emerging technologies to treat cancer;Medical Oncology;2023-10-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3